USFDA concludes Pre-Approval inspection at Zydus Lifesciences’ Ahmedabad facility

20 Feb 2026 Evaluate

US Food and Drug Administration (USFDA) has concluded Pre-Approval Inspection (PAI) for Injectable Medical Devices at Zydus Lifesciences’ unit 9 facility located at Zydus Biotech Park, Changodar, Ahmedabad. The inspection was conducted from February 16, 2026 to February 19, 2026.  The inspection closed with Nil observations. 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

904.10 -8.85 (-0.97%)
09-Mar-2026 13:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1810.35
Dr. Reddys Lab 1285.90
Cipla 1319.75
Zydus Lifesciences 904.10
Lupin 2293.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×